EQS-CMS: BP p.l.c.: Release of a capital market information
PAUL Tech AG: PAUL Tech Group enters into Receivables Financing ...
Enda Tamweel maintains its commitment to financial governance ...
SYNLAB AG publishes Joint Reasoned Statement on public acquisition ...
LANXESS Aktiengesellschaft: Release according to Article 40 Section ...
fox e-mobility AG:Â Announcement of the date of the Annual General ...
Bilfinger SE: Release according to Article 40 Section 1 of the ...
Purchase offer to the holders of bonds issued by Petroleos de ...
Knorr-Bremse AG: Dr. Nicolas Lange, buy
Purchase offer to the holders of bonds issued by Venezuela Bolivarian ...
Edison issues initiation on Dar Global (DAR): More luxury brand ...
Heidelberg Pharma Presents New Clinical Data from its Lead Candidate ...
Edison issues update on VietNam Holding (VNH): Consistently outperforming ...
NORMA Group SE adjusts sales guidance for the current fiscal ...
LANXESS Aktiengesellschaft: Release according to Article 40 Section ...
DEMIRE Deutsche Mittelstand Real Estate AG: Preliminary announcement ...
Invitation to the conference call of ZEAL Network SE
Cognite Releases Industry's First Definitive Guide to Generative ...
SAFE Fertility Group Plc enjoys trading debut on SET
Liquidation of JPMorgan ETFs (Ireland) - RMB Ultra-Short Income ...
JPMorgan ETFs (Ireland) ICAV: Dividend Declaration
WashTec AG: Preliminary announcement of the publication of quarterly ...
BASF SE: Release according to Article 40 Section 1 of the WpHG ...
SBF AG: Robert Stöcklinger, buy
BASF SE: Release according to Article 40 Section 1 of the WpHG ...
SBF AG: Robert Stöcklinger, buy
BASF SE: Release according to Article 40 Section 1 of the WpHG ...
WashTec AG: Preliminary announcement of the publication of financial ...
adesso SE increases sales by 28 % to EUR 833 million after nine ...
GE HealthCare Announces New Data Validating Artificial Intelligence ...
Northern Data AG provides Financial Update & Guidance
EQS-CMS: Fresenius Medical Care AG & Co. KGaA: Release according ...
MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in ...